METAPNEUMOVIRUS INFECTION
Clinical trials for METAPNEUMOVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new METAPNEUMOVIRUS INFECTION trials appear
Sign up with your email to follow new studies for METAPNEUMOVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One shot, three viruses: new vaccine trial for seniors
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new vaccine that aims to protect against three respiratory viruses at once: RSV, hMPV, and PIV3. About 390 adults aged 60 and older received different combinations of the vaccine to check safety and whether it helps the body make protective antibod…
Matched conditions: METAPNEUMOVIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 10:40 UTC
-
New mRNA vaccine aims to fight two respiratory viruses at once
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested an experimental mRNA vaccine designed to protect against two respiratory viruses: RSV and hMPV. Healthy adults aged 18-49 and 60+ received a single shot at different doses. Researchers monitored safety and immune responses for about 6 months.
Matched conditions: METAPNEUMOVIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:41 UTC